Pet Arthritis Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Pet Arthritis Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
The Pet Arthritis study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The increasing companion animal population, growing prevalence of arthritis, rising risk factors for the disease, supportive awareness programs initiated by governments, and strategies implemented by key companies are some of the key factors driving the market.
This report aims to provide a comprehensive presentation of the global market for Pet Arthritis study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Pet Arthritis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pet Arthritis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Osteoarthritis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pet Arthritis include Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC., Vetoquinol, NexGen Pharmaceuticals and Norbrook and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Pet Arthritis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Pet Arthritis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pet Arthritis Market Segment Percentages, by Type, 2021 (%)
Osteoarthritis
Other Arthritis
Global Pet Arthritis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pet Arthritis Market Segment Percentages, by Application, 2021 (%)
Dogs
Cats
Others
Global Pet Arthritis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pet Arthritis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Arthritis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pet Arthritis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Virbac
Elanco
Boehringer Ingelheim International GmbH
Ceva
Dechra Pharmaceuticals PLC.
Vetoquinol
NexGen Pharmaceuticals
Norbrook
Eltech K-Laser s.r.l.
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Pet Arthritis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pet Arthritis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pet Arthritis Overall Market Size
2.1 Global Pet Arthritis Market Size: 2021 VS 2028
2.2 Global Pet Arthritis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pet Arthritis Players in Global Market
3.2 Top Global Pet Arthritis Companies Ranked by Revenue
3.3 Global Pet Arthritis Revenue by Companies
3.4 Top 3 and Top 5 Pet Arthritis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pet Arthritis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pet Arthritis Players in Global Market
3.6.1 List of Global Tier 1 Pet Arthritis Companies
3.6.2 List of Global Tier 2 and Tier 3 Pet Arthritis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pet Arthritis Market Size Markets, 2021 & 2028
4.1.2 Osteoarthritis
4.1.3 Other Arthritis
4.2 By Type - Global Pet Arthritis Revenue & Forecasts
4.2.1 By Type - Global Pet Arthritis Revenue, 2017-2022
4.2.2 By Type - Global Pet Arthritis Revenue, 2023-2028
4.2.3 By Type - Global Pet Arthritis Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pet Arthritis Market Size, 2021 & 2028
5.1.2 Dogs
5.1.3 Cats
5.1.4 Others
5.2 By Application - Global Pet Arthritis Revenue & Forecasts
5.2.1 By Application - Global Pet Arthritis Revenue, 2017-2022
5.2.2 By Application - Global Pet Arthritis Revenue, 2023-2028
5.2.3 By Application - Global Pet Arthritis Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Pet Arthritis Market Size, 2021 & 2028
6.2 By Region - Global Pet Arthritis Revenue & Forecasts
6.2.1 By Region - Global Pet Arthritis Revenue, 2017-2022
6.2.2 By Region - Global Pet Arthritis Revenue, 2023-2028
6.2.3 By Region - Global Pet Arthritis Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pet Arthritis Revenue, 2017-2028
6.3.2 US Pet Arthritis Market Size, 2017-2028
6.3.3 Canada Pet Arthritis Market Size, 2017-2028
6.3.4 Mexico Pet Arthritis Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pet Arthritis Revenue, 2017-2028
6.4.2 Germany Pet Arthritis Market Size, 2017-2028
6.4.3 France Pet Arthritis Market Size, 2017-2028
6.4.4 U.K. Pet Arthritis Market Size, 2017-2028
6.4.5 Italy Pet Arthritis Market Size, 2017-2028
6.4.6 Russia Pet Arthritis Market Size, 2017-2028
6.4.7 Nordic Countries Pet Arthritis Market Size, 2017-2028
6.4.8 Benelux Pet Arthritis Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pet Arthritis Revenue, 2017-2028
6.5.2 China Pet Arthritis Market Size, 2017-2028
6.5.3 Japan Pet Arthritis Market Size, 2017-2028
6.5.4 South Korea Pet Arthritis Market Size, 2017-2028
6.5.5 Southeast Asia Pet Arthritis Market Size, 2017-2028
6.5.6 India Pet Arthritis Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pet Arthritis Revenue, 2017-2028
6.6.2 Brazil Pet Arthritis Market Size, 2017-2028
6.6.3 Argentina Pet Arthritis Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pet Arthritis Revenue, 2017-2028
6.7.2 Turkey Pet Arthritis Market Size, 2017-2028
6.7.3 Israel Pet Arthritis Market Size, 2017-2028
6.7.4 Saudi Arabia Pet Arthritis Market Size, 2017-2028
6.7.5 UAE Pet Arthritis Market Size, 2017-2028
7 Players Profiles
7.1 Zoetis
7.1.1 Zoetis Corporate Summary
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Pet Arthritis Major Product Offerings
7.1.4 Zoetis Pet Arthritis Revenue in Global Market (2017-2022)
7.1.5 Zoetis Key News
7.2 Virbac
7.2.1 Virbac Corporate Summary
7.2.2 Virbac Business Overview
7.2.3 Virbac Pet Arthritis Major Product Offerings
7.2.4 Virbac Pet Arthritis Revenue in Global Market (2017-2022)
7.2.5 Virbac Key News
7.3 Elanco
7.3.1 Elanco Corporate Summary
7.3.2 Elanco Business Overview
7.3.3 Elanco Pet Arthritis Major Product Offerings
7.3.4 Elanco Pet Arthritis Revenue in Global Market (2017-2022)
7.3.5 Elanco Key News
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Corporate Summary
7.4.2 Boehringer Ingelheim International GmbH Business Overview
7.4.3 Boehringer Ingelheim International GmbH Pet Arthritis Major Product Offerings
7.4.4 Boehringer Ingelheim International GmbH Pet Arthritis Revenue in Global Market (2017-2022)
7.4.5 Boehringer Ingelheim International GmbH Key News
7.5 Ceva
7.5.1 Ceva Corporate Summary
7.5.2 Ceva Business Overview
7.5.3 Ceva Pet Arthritis Major Product Offerings
7.5.4 Ceva Pet Arthritis Revenue in Global Market (2017-2022)
7.5.5 Ceva Key News
7.6 Dechra Pharmaceuticals PLC.
7.6.1 Dechra Pharmaceuticals PLC. Corporate Summary
7.6.2 Dechra Pharmaceuticals PLC. Business Overview
7.6.3 Dechra Pharmaceuticals PLC. Pet Arthritis Major Product Offerings
7.6.4 Dechra Pharmaceuticals PLC. Pet Arthritis Revenue in Global Market (2017-2022)
7.6.5 Dechra Pharmaceuticals PLC. Key News
7.7 Vetoquinol
7.7.1 Vetoquinol Corporate Summary
7.7.2 Vetoquinol Business Overview
7.7.3 Vetoquinol Pet Arthritis Major Product Offerings
7.7.4 Vetoquinol Pet Arthritis Revenue in Global Market (2017-2022)
7.7.5 Vetoquinol Key News
7.8 NexGen Pharmaceuticals
7.8.1 NexGen Pharmaceuticals Corporate Summary
7.8.2 NexGen Pharmaceuticals Business Overview
7.8.3 NexGen Pharmaceuticals Pet Arthritis Major Product Offerings
7.8.4 NexGen Pharmaceuticals Pet Arthritis Revenue in Global Market (2017-2022)
7.8.5 NexGen Pharmaceuticals Key News
7.9 Norbrook
7.9.1 Norbrook Corporate Summary
7.9.2 Norbrook Business Overview
7.9.3 Norbrook Pet Arthritis Major Product Offerings
7.9.4 Norbrook Pet Arthritis Revenue in Global Market (2017-2022)
7.9.5 Norbrook Key News
7.10 Eltech K-Laser s.r.l.
7.10.1 Eltech K-Laser s.r.l. Corporate Summary
7.10.2 Eltech K-Laser s.r.l. Business Overview
7.10.3 Eltech K-Laser s.r.l. Pet Arthritis Major Product Offerings
7.10.4 Eltech K-Laser s.r.l. Pet Arthritis Revenue in Global Market (2017-2022)
7.10.5 Eltech K-Laser s.r.l. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Pet Arthritis Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|